Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$38.8M
-7.1% from 2023
Prescriptions
121K
$319.81 per claim
Patients
47K
39,236 prescribers
Total spending, 2024
$38.9M
$825.90 per patient
Medicare prescription drug plans paid $38.8M for Pulmicort Flexhaler in 2024, for 121,457 prescriptions and refills to 47,023 patients (down 7.1% from 2023). The average cost per claim was $319.81.
California had the highest Medicare cost for Pulmicort Flexhaler in 2024: $4.4M for 13,921 claims, followed by Michigan ($3.2M).
Raymond D Petit, critical care (intensivists) in Attleboro, MA, had the highest Medicare cost for Pulmicort Flexhaler in 2024: 165 claims costing $76K.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Raymond D Petit Attleboro, MA | Critical Care (Intensivists) | 165 | 40 | $76K |
| Jason B Karp Lake Success, NY | Pulmonary Disease | 83 | 24 | $44K |
| Regina Frants |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 40,536 | 139,193 | 49,808 | $46.9M |
| 2023 | 37,243 | 117,659 | 43,936 | $41.8M |
| 2024 | 39,236 | 121,457 | 47,023 | $38.8M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Pulmonary Disease |
| 83 |
| 18 |
| $26K |
| Reuven Moshenyat Brooklyn, NY | Pulmonary Disease | 90 | 28 | $22K |
| Joseph Grizzanti Hawthorne, NJ | Pulmonary Disease | 46 | 12 | $20K |
| Gregory S Stone Ypsilanti, MI | Pulmonary Disease | 41 | 13 | $18K |
| Gregory D Gerboth Anchorage, AK | Pulmonary Disease | 22 | Under 11 | $17K |
| Paul M Kentor Highland Park, IL | Allergy/ Immunology | 33 | 12 | $17K |
| Justina Workman Hagerstown, MD | Nurse Practitioner | 42 | 16 | $16K |
| John Russomanno Hartford, CT | Pulmonary Disease | 29 | 12 | $16K |
| Gerard B Hayes Brighton, MA | Critical Care (Intensivists) | 33 | Under 11 | $16K |
| Gregory V Marcotte Wilmington, DE | Allergy/ Immunology | 37 | Under 11 | $15K |
| Mohamad Y Tawila Royal Oak, MI | Allergy/ Immunology | 38 | 12 | $15K |
| Jacqueline A Chang La Jolla, CA | Pulmonary Disease | 41 | 17 | $15K |
| Kaiser Toosy New Haven, CT | Pulmonary Disease | 49 | 11 | $15K |
| Kevin C Patterson Grand Rapids, MI | Pulmonary Disease | 28 | Under 11 | $15K |
| Saima J Ansari Vernon, CT | Pulmonary Disease | 19 | Under 11 | $15K |
| Srilatha A Lazzaro Sheboygan, WI | Allergy/ Immunology | 29 | Under 11 | $15K |
| Mohammedi N Savliwala Bloomfield Hills, MI | Allergy/ Immunology | 30 | 11 | $14K |
| Shawna Moore Danbury, CT | Nurse Practitioner | 20 | Under 11 | $14K |
| Robert O Go Rochester Hills, MI | Pulmonary Disease | 33 | 13 | $14K |
| Paulette Ong Davenport, IA | Physician Assistant | 33 | Under 11 | $14K |
| Michael T McAvoy Saginaw, MI | Allergy/ Immunology | 28 | 11 | $14K |
| Fernando A Keller Boynton Beach, FL | Internal Medicine | 46 | 19 | $14K |
| Ryan Eid Duxbury, MA | Allergy/ Immunology | 31 | Under 11 | $14K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| H2 Pharma LLC | 115,507 | $37.3M |
| Astrazeneca AZN | 5,993 | $1.6M |